Imatinib Mesylate Therapy in Late Ph+ Chronic Myeloid Leukemia Patients in Stable Complete Cytogenetic Response after Interferon-Alpha Results in a Very High Complete Molecular Response Rate / Alimena, G; Breccia, M; Luciano, L; Quarantelli, F; Diverio, D; Izzo, B; De Angelis, B; Mancini, M; Latagliata, R; Carmsoino, I; Nanni, M; Rotoli, B; Mandelli, F; Pane, F.. - In: BLOOD. - ISSN 0006-4971. - 108:(2006). (Intervento presentato al convegno ASH).
Imatinib Mesylate Therapy in Late Ph+ Chronic Myeloid Leukemia Patients in Stable Complete Cytogenetic Response after Interferon-Alpha Results in a Very High Complete Molecular Response Rate
Breccia M;
2006
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
